On 26 September the University of Sydney launched a new website to help health professionals deal with the wide range of challenging ethical and legal issues they constantly encounter in their work.

The development of prediction models that included variables such as pretreatment sexual function, patient characteristics and treatment factors appear to be effective at predicting erectile function 2 years after prostatectomy, external radiotherapy, or brachytherapy for prostate cancer, according to a study in the September 21 issue of JAMA.

Men who maintain a healthy body throughout life are often better able to fight off diseases like cancer. That's why experts at The University of Texas MD Anderson Cancer Center have created a guide with cancer prevention tips to help men at every stage of life.

Curcumin, the main component in the spice turmeric, suppresses a cell signaling pathway that drives the growth of head and neck cancer, according to a pilot study using human saliva by researchers at UCLA's Jonsson Comprehensive Cancer Center.

The results show that women who used IUDs halved the risk of developing cervical cancer compared to those that had not ever used these devices. These results are contrary to popular belief that IUDs could be a risk factor of cervical cancer. Previous studies on possible effects of IUD use on the development of this cancer have yielded inconsistent results.

Delcath Systems, Inc. (NASDAQ: DCTH) announced that updated results from the metastatic neuroendocrine tumour (mNET) cohort of the Company's recently completed Phase 2 clinical trial were presented at the Cardiovascular and Interventional Radiological Society of Europe (CIRSE) congress held this week in Munich, Germany. James F. Pingpank, MD, FACS, Associate Professor of Surgery at ...

Gene therapy delivered directly to a particularly stubborn type of breast cancer cell causes the cells to self-destruct, lowers chance of recurrence and helps increase the effectiveness of some types of chemotherapy, researchers at The University of Texas MD Anderson Cancer Center reported in the Sept. 13 edition of Cancer Cell.

With the culmination of the 18-year-long 'Fremantle Diabetes Study', a startling new link has been revealed between type 2 diabetes and colorectal cancer in men.

Nektar Therapeutics (Nasdaq: NKTR) announced on Sept 9th that positive results from the company's Phase 2 clinical study of NKTR-102 in patients with metastatic breast cancer were presented at the ASCO 2011 Breast Cancer Symposium in San Francisco, California. NKTR-102 is a novel topoisomerase I inhibitor designed using Nektar's proprietary polymer conjugate technology, and ...

Scientists from the Genome Institute of Singapore (GIS), an institute of the Agency for Science, Technology and Research (A*STAR), and their colleagues at the National University of Singapore (NUS), have uncovered a new way to target EZH2, an enzyme that promotes the estrogen receptor-negative breast cancer, a type of breast cancer that is aggressive and unresponsive to current forms of ...